Update on biosimilars in Canada - April 2021

Published date03 May 2021
Subject MatterPatent Litigation,Pharmaceutical Industry,Intellectual Property Protection,Life Sciences,Health Canada,Pharmaceutical Patents,Patents,Patent Infringement,Biosimilars,Biologics,Canada
AuthorUrszula Wojtyra
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT